orthofix
-
Financial
Orthofix and SeaSpine Announce John Bostjancic to Serve as CFO for Combined Company Post Closing
LEWISVILLE, Texas and CARLSBAD, Calif., Nov. 18, 2022 (GLOBE NEWSWIRE) — Orthofix (NASDAQ: OFIX), a global medical device company with…
Read More » -
Extremities
Orthofix Announces First Patient Implants with Legacy Demineralized Bone Matrix for Spine, Pelvic and Extremities Procedures
LEWISVILLE, TEXAS – October 13, 2022 – OrthoSpineNews – Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine…
Read More » -
Biologics
Orthofix and MTF Biologics Recognized with 2022 Spine Technology Award for Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS — October 12, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Spine
Orthofix and SeaSpine to Combine in Merger of Equals to Create Leading Global Spine and Orthopedics Company
Highly complementary spine and orthopedics portfoliosOne of the industry’s broadest biologics and regenerative technology offeringsDifferentiated and synergistic enabling technologiesMeaningful cross-selling…
Read More » -
Spine
Orthofix Announces Presentation of Long-Term Evidence Highlighting the Clinical Management of Cervical Disc Arthroplasty at North American Spine Society Annual Meeting
Data includes results from five-year multi-center IDE study in U.S. of the M6-C disc that also demonstrated strong clinical performance,…
Read More » -
Financial
Orthofix Reports Second Quarter 2022 Results
Net sales of $118.1 million, a decrease of 3% on a reported basis and flat on a constant currency basis…
Read More » -
Biologics
Orthofix Announces First Clinical Use of Virtuos Lyograft – a First-of-Its-Kind, Shelf-Stable and Complete Autograft Substitute for Spine and Orthopedic Procedures
LEWISVILLE, TEXAS – July 26, 2022 /OrthoSpineNews/ — Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and…
Read More » -
Spine
Orthofix M6-C Artificial Cervical Disc IDE Study Data to be Presented at ISASS Demonstrates Continued Statistically Significant Benefits at Five Years
Additionally, analysis of two-year physiological range of motion data from multiple artificial cervical disc IDE studies to be presented showing…
Read More » -
Regulatory
FDA Grants PMA for the AccelStim Bone Growth Stimulation Device — Expanding Orthofix’s Portfolio of Market-Leading Bone Healing Therapy Solutions
May 4, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Biologics
Orthofix and MTF Biologics Expand Partnership Agreement
May 3, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Spine
Orthofix Announces New Business Unit President
Kimberley Elting, Chief Legal and Development Officer for Orthofix, Appointed to Lead Global Orthopedics Business April 8, 2022 LEWISVILLE, Texas–(BUSINESS…
Read More » -
Regulatory
Orthofix Announces FDA Clearance and First Patient Cases With the TrueLok EVO Ring Fixation System
Designed for complex limb reconstruction and deformity correction procedures, the system features radiolucent rings and struts for clearer visualization under…
Read More » -
Financial
Orthofix Reports Fourth Quarter and Fiscal Year 2021 Results
Fourth quarter net sales of $125.1 million, an increase of 6% over the prior year2021 annual net sales of $464.5…
Read More » -
Biologics
Orthofix Expands Synthetic Bone Growth Offerings with Full Market Launch of Opus BA – a Bioactive Solution for Spine Procedures
February 22, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More » -
Financial
Orthofix Announces Investment and Partnership with nView medical, Developer of Novel Imaging and Guidance Systems
January 19, 2022 LEWISVILLE, Texas–(BUSINESS WIRE)–Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus,…
Read More »